Skip to content

Application Study of Multiparametrric Magnetic Resonance Imaging (mpMRI) based on Artificial Intelligence for the detection ,diagnosis and assessment of pulmonary nodules

Application Study of Multiparametrric Magnetic Resonance Imaging (mpMRI) based on Artificial Intelligence for the detection ,diagnosis and assessment of pulmonary nodules

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400094100
Enrollment
Unknown
Registered
2024-12-17
Start date
2023-06-16
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung lesions

Interventions

Gold Standard:physiology
Index test:Assessment of benign and malignant lung lesions, pathological typing and staging using MRI multiple sequence quantitative parameters

Sponsors

Shanghai Changzheng Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
28 Years to 81 Years

Inclusion criteria

Inclusion criteria: People with previous chest CT suggesting the presence of lung nodules, people at high risk of lung cancer, people with lung cancer, people>=40 years old (risk-exposed people)

Exclusion criteria

Exclusion criteria: 1) Those with electronic implants such as pacemakers, neurostimulators, insulin pumps, cochlear implants, etc; 2) Those who have had aneurysm surgery and intracranial with aneurysm clips; 3) Those who have had heart surgery and use of artificial heart valves; 4) History of lung surgery; 5) Those who have metal foreign bodies, metal implants or metal prosthesis in the body; 6) Pregnant women, nursing mothers and those who have birth plan; 7) Critically ill patients who need to use life support system; 8) Uncontrolled epilepsy or mental illness, who cannot cooperate with MRI; 9) Severe claustrophobia, who can not cooperate with the magnetic resonance examination; 10) Patients with neurological disorders such as damage to the respiratory center that result in the inability to inhale and hold the breath normally; (11) Coughing, coughing up sputum or dyspnea patients who cannot breathe in and out normally; (12) Older patients with limited mobility and difficulty in taking care of themselves, or those who have difficulty in arriving at the test site; (13) Other conditions that the clinical trial personnel consider inappropriate to participate in this trial.

Design outcomes

Primary

MeasureTime frame
Apparent diffusion coefficient;Radiomics Features;

Countries

China

Contacts

Public ContactYi Xia

Shanghai Changzheng Hospital

yi_xia_07@163.com+86 136 0189 3287

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026